Are you a nurse? Join the iris network!
Video iris seen from the sky
Video iris seen from the sky
Video : iris seen from the hearth
Summary 3 - Edito 4 - La radiothérapie, au coeur du traitement des cancers…(Pr Dirk Van Gestel)
Live life to the full in 2018!
A science platform to combat brain metastases
24/05/2018 : Famous brussels restaurateurs will create a large chain of solidarity for the benefit of the "Friends of the Institut Bordet" and the research.
Personalised patient follow-up during oral anticancer treatment (Press release)
Professor Martine Piccart receives the prestigious ARC Foundation Léopold Griffuel Award for translational and clinical research
On Thursday April 5th, the Professor Martine Piccart received the 46th Prix Fondation ARC Léopold Griffuel for translationnal and clinical research. This prestigious prize rewards annually researchers of international rewnown whose work has resulted in a major advance in cancer research.
1 milliard de retombées économiques et près de 7.800 emplois générés à Bruxelles en 2016.
The Jules Bordet Institute is developing an innovative digital tool to support patients in their decision-making. To develop, with the assistance of patients, a digital tool that enables patients to decide in full knowledge of the fact
The administration of an anti-inflammatory drug during the ablation of the primary tumour reduces the risk of breast cancer recurrence in overweight or obese patients
We're full of the joys of spring. But be careful what it might bring! Here are a few tips to avoid melanoma now that spring has sprung.
Prize awarded to the researcher Christine Desmedt of the Jules Bordet Institute, ULB.
Double Merit Award of the Conquer Cancer Foundation of ASCO for 2 young researchers at the Institut Jules Bordet
Oncodistinct, a multidisciplinary clinical research network that meets patients' needs
05/06/2018 : Gastronomic evening benefiting the research laboratories of the new Institut Bordet
DRAW : 04/07/2018 - 1st prize: a stay for 2 people in VIENNA
(Dr Ignatiadis) A patient’s immune response makes it possible to personalize treatment of HER2 positive breast cancer.
On the occasion of World No Tobacco Day the Jules Bordet Institute separates the myths from the facts